Comparison of Narrow and Regular Implants
The Comparison of Narrow and Regular Platform Dental Implants Placed Posterior Regions
1 other identifier
observational
51
1 country
1
Brief Summary
The study was designed as a retrospective, parallel, two years longitudinal pilot trial. Twenty-eight patients (mean age: 48.34 ± 6.06) aged between 35 and 60 years and 66 TiUnite surfaces (Nobel Biocare Parallel Conical Connection), bone level dental implant were included in the study. The implants were divided into two different groups according to the NPIs and regular platform implants(RPIs). The mean implant lengths, plaque index(PI), gingival index(GI), periodontal pocket depth(PD), gingival recession(GR), keratinized gingival width(KGW) and bleeding on probing(BOP) values were recorded. The Student's t-test used for between-group comparison.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2019
CompletedFirst Submitted
Initial submission to the registry
September 24, 2020
CompletedFirst Posted
Study publicly available on registry
October 1, 2020
CompletedOctober 1, 2020
September 1, 2020
2 months
September 24, 2020
September 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Marginal bone loss
Peri-implant alveolar bone loss measurements on software program
change from baseline marginal bone loss at postoperatively 24. month
Secondary Outcomes (1)
Keratinized gingival width
change from baseline peri-implant keratinized gingival width at postoperatively 24. month
Study Arms (2)
Narrow platform implant
All measurements will be obtained after dental implant functional loading. Periodontal index will be recorded and alveolar bone loss measurements will be made on periapical radiographs.
Regular platform implants
All measurements will be obtained after dental implant functional loading. Periodontal index will be recorded and alveolar bone loss measurements will be made on periapical radiographs.
Interventions
alveolar bone loss measurement on standardized parallel periapical radiograph
Eligibility Criteria
All dental implants involved are the Nobel Biocare Parallel CC brand (Nobel Biocare, Gothenburg, Sweden) with a TiUnite surface, and it defined a regular diameter of 4.3 mm and narrow diameter of 3.75 mm. Dental implants divided into two groups according to implant diameter, the NPI group comprised 3.75 mm diameter (NP, Ø= 3.75 mm) implants, and the RPI group comprised 4.3 mm diameter (RP, Ø= 4.3mm) implants (implant lengths: 10 mm-13 mm).
You may qualify if:
- the presence of a dental implant treated with fixed prosthetic restoration placed in the posterior jaw followed for at least one year after functional loading,
- no active periodontal disease,
- no history of penicillin allergy -
- no radiotherapy to the head and neck region
- smoking less than ten cigarettes per day,
- no bone augmentation surgery before or during dental implant surgery,
- aged over 18,
- mesial or distal additional crown restoration was not performed,
- no use of medications that affect bone metabolism and
- not pregnant or lactating.
You may not qualify if:
- the implants placed in the anterior region,
- immediate placing and loading
- augmented before or using a graft membrane with surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kütahya Health Sciences University Faculty of Dentistry
Kütahya, 43100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Berceste Guler, PhD
Kütahya Health Sciences University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist Prof
Study Record Dates
First Submitted
September 24, 2020
First Posted
October 1, 2020
Study Start
June 27, 2019
Primary Completion
August 31, 2019
Study Completion
October 28, 2019
Last Updated
October 1, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share